Inhoudsopgave:
|
\u003cp\u003e\u003ci\u003eEpigenetic Regulation of Cancer in Response to Chemotherapy, Volume 158\u003c/i\u003e of the \u003ci\u003eAdvances in Cancer Research\u003c/i\u003e series, highlights new advances in the field, with this new volume presenting chapters on timely topics, including Epigenetically Programmed Resistance to Chemotherapy and Promotion of Immune Evasion in Cancer, A Role for the Epigenome in Cancer Cell Drug Tolerance, Histone Methylation and X Chromosomal Genes in Metastasis of Breast Cancer, Targeting Epigenetic Regulation Using Small Molecule Inhibitors, Histone Deacetylase Inhibitors as Sanguine Epigenetic Therapeutics against Pugnacious Lung Cancer, From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (Artemia), and more.\u003c/p\u003e \u003cp\u003eAdditional chapters cover Predictive Models of Chemoresistance Generated by Crunching the Public Drug Screen, Epigenomic and Genomic Profiling Datasets via Regression-, Machine Learning, and Knowledge-Based Methods, Probing on the Mechanisms of lncRNAs on Cancer Drug Resistance, Drug Tolerant Persister Cells in Cancer: Current Knowledge and Therapeutic Perspectives, and much more.\u003c/p\u003e\u003cul\u003e \u003cli\u003eProvides the authority and expertise of leading contributors from an international board of authors\u003c/li\u003e \u003cli\u003ePresents the latest release in the \u003ci\u003eAdvances in Cancer Research\u003c/i\u003e series\u003c/li\u003e \u003cli\u003eIncludes the latest information on the \u003ci\u003eEpigenetic Regulation of Cancer in Response to Chemotherapy\u003c/i\u003e\u003c/li\u003e\u003c/ul\u003e |
nl
en